Back
ManpowerGroup 10K Form
Sell
34
MAN
ManpowerGroup
Last Price:
$42.29
Seasonality Move:
-0.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-03 | 10Q | MAN/ManpowerGroup Quarterly |
2023-08-04 | 10Q | MAN/ManpowerGroup Quarterly |
2023-05-05 | 10Q | MAN/ManpowerGroup Quarterly |
2022-11-07 | 10Q | MAN/ManpowerGroup Quarterly |
2022-08-05 | 10Q | MAN/ManpowerGroup Quarterly |
2022-05-06 | 10Q | MAN/ManpowerGroup Quarterly |
Receive MAN News And Ratings
See the #1 stock for the next 7 days that we like better than MAN
MAN Financial Statistics
Sales & Book Value
Annual Sales: | $17.9B |
---|---|
Cash Flow: | $-166.9M |
Price / Cash Flow: | 7.49 |
Annual Sales: | $44.99 |
Price / Book: | 0.94 |
Profitability
EPS (TTM): | 2.30000 |
---|---|
Net Income (TTM): | $111M |
Gross Margin: | $3.1B |
Return on Equity: | 5.17% |
Return on Assets: | 1.33% |
ManpowerGroup Earnings Forecast
Key ManpowerGroup Financial Ratios
-
The Gross Profit Margin over the past 35 years for MAN is 17.29%.
-
The Selling, General & Administrative Expenses for MAN have been equal to 15.58% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 62.03% of Operating Income.
-
The Net Earning history of MAN is 0.81% of Total Revenues.
-
Per Share Earnings over the last 35 years have been positive in 23 years.
ManpowerGroup Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Professional Services |
Sector: | Industrials |
Current Symbol: | MAN |
CUSIP: | 56418H |
Website: | manpowergroup.com |
Debt
Debt-to-Equity Ratio: | 0.51 |
---|---|
Current Ratio: | 1.12 |
Quick Ratio: | 1.08 |
Price-to-Earnings
Trailing P/E Ratio: | 14.1 |
---|---|
Forward P/E Ratio: | 9.66 |
MAN Technical Analysis vs Fundamental Analysis
Sell
34
ManpowerGroup (MAN)
is a Sell
Is ManpowerGroup a Buy or a Sell?
-
ManpowerGroup stock is rated a SellThe current ManpowerGroup [MAN] share price is $42.43. The Score for MAN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.